Epstein Secrets

at current levels. The fundamental bull case for Health rests on the strong pipeline of new products for

ariables like 10-year Treasury yields, gold and S/yen also hit oversold levels. The models are useful in isolation for highlighting any anomalies in Bankof America Merrill Lynch European Equity Strategy |01 December 2016 = 21 HOUSE_OVERSIGHT_014480 --- PAGE BREAK --- recent price action for individual assets. However, the

h Personnel (including the analyst(s) responsible for this report) receive compensation based upon, among other factors, the overall profitability of Bank of America Corporation, including profits derived from investment banking. The analyst(s) responsible for this report may also receive compensation based upon, a

errill Lynch (Singapore) (Company Registration Nos F 06872E and 198602883D respectively). MLIBLMB and Merrill Lynch (Singapore} are regulated by MAS. Bank of America N.A, Australian Branch (ARBN 064 874 531), AFS License 412901 (BANA Australia) and Merrill Lynch Equities (Australia) Limited (ABN 65 006 276 795), AFS L

3% -] 2% 74 3.1% = 2% 3.2 -0.4% 0 54% 0.9% SXDP (Health) 3.1% -0.6% 2% 86% 0.9% -/ 2% 115 24% -14 2% 4]

h Personnel (including the analyst(s) responsible for this report) receive compensation based upon, among other factors, the overall profitability of Bank of America uding profits derived from investment banking. The analyst(s) responsible for this report may also receive compensation based upon, among other factor

LP iliates d hority; Lynch International (DIFC Branch), regulated by t ores; Merrill Lynch (Brazi bia Company, regu n and is d PRA) by MLI (UK) and Bank of America Merrill Lynch Intern (as defined in the rules o Financial | Lynch (Ti ned under the Financia and 198602883D respec Lynch }: Bank he Capi by Merrill xtent of our al

and distributed in Singapore to institutional International Bank Limited (Merchant Bank) (MLIBLMB) and Merrill Lynch ingapore) are regulated by MAS. Bank of America N.A,, Australian Branch (ARBN e this report in Australia only to affiliates involved in preparing this research report is an pproval is required for publ

at current levels. The fundamental bull case for Health rests on the strong pipeline of new products for

h Personnel (including the analyst(s) responsible for this report) receive compensation based upon, among other factors, the overall profitability of Bank of America Corporation, including profits derived from investment banking. The analyst(s) responsible for this report may also receive compensation based upon, a

errill Lynch (Singapore) (Company Registration Nos F 06872E and 198602883D respectively). MLIBLMB and Merrill Lynch (Singapore} are regulated by MAS. Bank of America N.A, Australian Branch (ARBN 064 874 531), AFS License 412901 (BANA Australia) and Merrill Lynch Equities (Australia) Limited (ABN 65 006 276 795), AFS L

-12 1% 78 3.0% -13 % 33 -0.4% 6 68% -0./% SXDP (Health) 3.0% -08% 1% 8.7% 0.9% 9 2% 115 2.5% -12 3% 40

vestment decision. Refer to important disclosures on page 28 to 29. Analyst Certification on page 27. 11756528 Timestamp: 20 June 2017 01:18AM EDT Bankof America Merrill Lynch 20) une 2017 Equity Derivatives Glob. al BofA Analytics = DATA DRIVEN = Global Equity Derivatives Rsch MLPI F&S Anshul Gupta

most recently available data which may be delayed in some cases. “Trade Value” represents current valuation of trades initiated on the “Open Date”. Bankof America Merrill Lynch Global Equity Volatility Insights | 20 June 2017. 25 HOUSE_OVERSIGHT_014996 --- PAGE BREAK --- Volatility in Numbers (16-Jun-17) Table 11: Stati

. DHR (US 1 name) top pick, also A, ZTS in Animal Health, BDX in Diagnostics & CTLT in Services. Medtech

ist Sales Global Equities Bank of America Merrill Lynch One Bryant Park | New York, 10036 | United States T: M: The power of global connections™ Bankof America Merrill Lynch Find all Conference Events via the Following Link: https://gems.bankofamerica.com Disclaimer: This material was prepared by Sector Sp

ncrease penetration of higher margin offerings 48 Health: Not Tremendously Prescriptive 51 Vision 2030 a s

errill Lynch (Singapore) (Company Registration Nos F 06872E and 198602883D respectively). MLIBLMB and Merrill Lynch (Singapore) are regulated by MAS. Bank of America N.A., Australian Branch (ARBN 064 874 531), AFS License 412901 (BANA Australia) and Merrill Lynch Equities (Australia) Limited (ABN 65 006 276 795), AFS L

ervices 1,720 Tax credit for orphan drug research Health 100 Exclusion & deferral of policyholder income e

oose to pay down debt over other uses of cash, in an attempt to skew their balance sheets less toward debt and more toward equity (see the section on no Bankof America <> Merrill Lynch Equity Strategy Focus Point | 29 January 2017 9 HOUSE_OVERSIGHT_023077 --- PAGE BREAK --- interest tax shield later in this repor